Femasys (FEMY) Cash from Financing Activities (2020 - 2026)

Femasys (FEMY) reported Cash from Financing Activities of $342334.0 for Q1 2026, down 93.45% on a YoY basis from $5.2 million in Q1 2025, and down 96.23% quarter-over-quarter from $9.1 million in Q4 2025.

Femasys (FEMY) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Femasys has reported Cash from Financing Activities for 7 years, with the latest figure at $342334.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 93.45% year-over-year to $342334.0; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (up 212.48% YoY), and the FY2025 full-year result was $25.1 million, up 1139.74% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $342334.0, down from $9.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $16.1 million in Q4 2023, with the low at -$362039.0 in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $2.9 million across 5 years, with a median of $824252.0 in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 100.32% — and 2023, when it surged 19751.64%.
  • Femasys' Cash from Financing Activities stood at -$81950.0 in 2022, then surged by 19751.64% to $16.1 million in 2023, then sank by 93.63% to $1.0 million in 2024, then surged by 785.15% to $9.1 million in 2025, then plunged by 96.23% to $342334.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $342334.0 (Q1 2026), $9.1 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Femasys 254.59 Mn 249.20 Mn - 342,334.00

Historic Data

Download Data
DateValue
Mar 31, 2026 342,334.00
Mar 31, 2026 342,334.00
Dec 31, 2025 9.08 Mn
Dec 31, 2025 9.08 Mn
Sep 30, 2025 6.98 Mn
Sep 30, 2025 6.98 Mn
Jun 30, 2025 3.85 Mn
Jun 30, 2025 3.85 Mn
Mar 31, 2025 5.23 Mn
Mar 31, 2025 5.23 Mn
Dec 31, 2024 1.03 Mn
Dec 31, 2024 1.03 Mn
Jun 30, 2024 223,549.00
Jun 30, 2024 223,549.00
Mar 31, 2024 778,175.00
Mar 31, 2024 778,175.00
Dec 31, 2023 16.10 Mn
Dec 31, 2023 16.10 Mn
Sep 30, 2023 870,329.00
Sep 30, 2023 870,329.00